Eye bulging drug gets Real-World checkup in china
NCT ID NCT07085117
Summary
This study looked back at medical records to see how well the drug teprotumumab worked for people with Thyroid Eye Disease (TED) in China. Researchers checked if the treatment reduced eye bulging (proptosis) and improved other symptoms for 5 patients who received it. The goal was to understand the real-world effectiveness and safety of this treatment outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boao Vanguard Hospital
Qionghai, Hainan, 571400, China
Conditions
Explore the condition pages connected to this study.